home All News open_in_new Full Article

European regulators OK Alzheimer’s treatment Leqembi after initial doubts

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer and then reconsidered it. The infused treatment from Japanese drugmaker Eisai and Biogen received approval for patients in early stages of the fatal, mind-robbing disease. The decision applies to all 27 members of the European Union […]


today 3 w. ago attach_file Economics

attach_file Politics
attach_file Technology
attach_file Other
attach_file Transport
attach_file Other
attach_file Other
attach_file Politics
attach_file Transport
attach_file Culture
attach_file Society
attach_file Other
attach_file Other
attach_file Politics
attach_file Science
attach_file Other
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Society


ID: 826650546
Add Watch Country

arrow_drop_down